{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:56:28Z","timestamp":1794542188776,"version":"4.9.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Context:<\/jats:title>\n            <jats:p>Little is known about when and how the ICD-10-CM diagnosis code for Post-COVID Conditions (PCC; U09.9) is being used to document PCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To examine the use and characteristics of clinical coding for PCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>A retrospective cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Transaction-level medical encounters, laboratory testing results, pharmacy claims, and medical claims for inpatient and outpatient care from the HealthVerity database.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Participants:<\/jats:title>\n            <jats:p>382 400\u00a0US adults and children with private health insurance, Medicare, and Medicaid who had U09.9 code documented during October 1, 2021-June 30, 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome Measures:<\/jats:title>\n            <jats:p>Count of first use of the U09.9 code, (a) overall, over time, and proportion by provider type; (b) prevalence of PCC-associated incident conditions co-documented with U09.9; (c) number of documented SARS-CoV-2 infections preceding U09.9; (d) timing between infection and U09.9; (e) encounters during the 6\u00a0months following first use of U09.9.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 0.6% of 65 556 068 patients had a PCC diagnosis code (64.6% female; 6 in 10 had \u22651 preexisting conditions). The highest count of new U09.9 codes occurred during Quarter 1 and Quarter 3 of 2022 and was documented by a variety of provider specialties. The most prevalent co-documented PCC-associated incident conditions were respiratory (13.4%) and malaise and fatigue (7.8%). Only 62% of patients had SARS-CoV-2 infection documented preceding U09.9; median time to PCC documentation was 17.0\u00a0days (interquartile range [IQR]\u00a0=\u00a05.0, 61.0). Patients with \u22651 encounters during which PCC was documented in the 6\u00a0months following their index encounter (n\u00a0=\u00a0109 794) had, on average, 25.5 additional encounters (median\u00a0=\u00a014 [IQR\u00a0=\u00a07, 29]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our study describes the sociodemographic characteristics, complex clinical manifestations, and high healthcare use of patients following a PCC diagnosis. These findings may inform efforts to identify and treat PCC, inform healthcare planning, and support efforts to educate clinicians about the definition of PCC and accurate application of the code.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phh.0000000000002137","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:00:24Z","timestamp":1741168824000},"page":"E292-E302","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Use and Characteristics of Clinical Coding for Post-COVID Conditions in a Retrospective US Cohort"],"prefix":"10.1097","volume":"31","author":[{"given":"Nicole D.","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia H.","family":"Koumans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Raykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Saydah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"R3-20250721","first-page":"1","article-title":"Long COVID in adults: United States, 2022","volume":"480","author":"Adjaye-Gbewonyo","year":"2023","journal-title":"NCHS Data Brief"},{"issue":"1","key":"R5-20250721","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02737-6","article-title":"Coding long COVID: characterizing a new disease through an ICD-10 lens","volume":"21","author":"Pfaff","year":"2023","journal-title":"BMC Med"},{"key":"R6-20250721","first-page":"2023.10.04.23296301","article-title":"Characterization of long COVID definitions and clinical coding practices","author":"Maripuri","year":"2023","journal-title":"medRxiv"},{"issue":"10","key":"R7-20250721","doi-asserted-by":"crossref","first-page":"e2235089","DOI":"10.1001\/jamanetworkopen.2022.35089","article-title":"Use of the postacute sequelae of COVID-19 diagnosis code in routine clinical practice in the US","volume":"5","author":"McGrath","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"R9-20250721","doi-asserted-by":"crossref","first-page":"e2225657","DOI":"10.1001\/jamanetworkopen.2022.25657","article-title":"Health care utilization in the 6 months following SARS-CoV-2 infection","volume":"5","author":"Tartof","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R10-20250721","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1038\/s41467-024-48022-9","article-title":"Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection","volume":"15","author":"Malden","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"R11-20250721","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12879-024-09076-8","article-title":"Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"31","key":"R12-20250721","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm7131a3","article-title":"Post\u2013COVID-19 symptoms and conditions among children and adolescents\u2014United States, March 1, 2020\u2013January 31, 2022","volume":"71","author":"Kompaniyets","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"R14-20250721","doi-asserted-by":"crossref","first-page":"866","DOI":"10.15585\/mmwr.mm7232a3","article-title":"Long COVID and significant activity limitation among adults, by age\u2014United States, June 1\u201313, 2022, to June 7\u201319, 2023","volume":"72","author":"Ford","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"R15-20250721","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15585\/mmwr.mm7306a4","article-title":"Notes from the field: long COVID prevalence among adults\u2014United States, 2022","volume":"73","author":"Ford","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"R17-20250721","first-page":"e14037","article-title":"Barriers to healthcare access and experiences of stigma: findings from a coproduced long covid case\u2010finding study","volume":"27","author":"Clutterbuck","year":"2024","journal-title":"Health Exp Int J Public Particip Health Care Health Policy"},{"issue":"6","key":"R19-20250721","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamainternmed.2023.0750","article-title":"Risk factors associated with post\u2212COVID-19 condition: a systematic review and meta-analysis","volume":"183","author":"Tsampasian","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"4","key":"R21-20250721","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amepre.2024.05.007","article-title":"Health insurance and access to care in U.S. working-age adults experiencing long COVID","volume":"67","author":"Ford","year":"2024","journal-title":"Am J Prev Med"},{"issue":"15","key":"R22-20250721","doi-asserted-by":"crossref","first-page":"560","DOI":"10.15585\/mmwr.mm7015e2","article-title":"Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region\u2014United States, March\u2013December 2020","volume":"70","author":"Romano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"R24-20250721","doi-asserted-by":"crossref","first-page":"e2134147","DOI":"10.1001\/jamanetworkopen.2021.34147","article-title":"Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic review and meta-analysis","volume":"4","author":"Magesh","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"R25-20250721","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1016\/j.focus.2023.100120","article-title":"Associations between insurance, race and ethnicity, and COVID-19 hospitalization beyond underlying health conditions: a retrospective cohort study","volume":"2","author":"McConnell","year":"2023","journal-title":"AJPM Focus"},{"key":"R26-20250721","doi-asserted-by":"crossref","first-page":"e11711","DOI":"10.1590\/1414-431x2021e11711","article-title":"Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age","volume":"55","author":"Fabi\u00e3o","year":"2022","journal-title":"Braz J Med Biol Res"},{"key":"R27-20250721","doi-asserted-by":"crossref","first-page":"102290","DOI":"10.1016\/j.pmedr.2023.102290","article-title":"Gender disparities in symptomology of COVID-19 among adults in Arkansas","volume":"35","author":"Patel","year":"2023","journal-title":"Prev Med Rep"},{"issue":"3","key":"R28-20250721","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacr.2008.11.013","article-title":"Effects of a computerized provider order entry system on clinical histories provided in emergency department radiology requisitions","volume":"6","author":"Alkasab","year":"2009","journal-title":"J Am Coll Radiol"},{"key":"R29-20250721","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2022.12.002","article-title":"Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID","volume":"128","author":"Tene","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"32","key":"R30-20250721","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm7232a2","article-title":"Prevalence of symptoms \u226412 months after acute illness, by COVID-19 testing status among adults\u2014United States, December 2020\u2013March 2023","volume":"72","author":"Montoy","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R31-20250721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"R32-20250721","doi-asserted-by":"crossref","first-page":"e230010","DOI":"10.1001\/jamahealthforum.2023.0010","article-title":"One-year adverse outcomes among US adults with post\u2013COVID-19 condition vs those without COVID-19 in a large commercial insurance database","volume":"4","author":"DeVries","year":"2023","journal-title":"JAMA Health Forum"},{"issue":"2","key":"R33-20250721","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"R34-20250721","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12913-022-08387-3","article-title":"Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis","volume":"22","author":"Koumpias","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"13","key":"R35-20250721","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm7113e1","article-title":"Use of at-home COVID-19 tests\u2014United States, August 23, 2021\u2013March 12, 2022","volume":"71","author":"Rader","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of Public Health Management &amp; Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHH.0000000000002137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T15:00:45Z","timestamp":1753110045000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHH.0000000000002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/phh.0000000000002137","relation":{},"ISSN":["1078-4659","1550-5022"],"issn-type":[{"value":"1078-4659","type":"print"},{"value":"1550-5022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]}}}